Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 2

Conditions

Gastrointestinal Stromal Tumors 2

Interventions

Imatinib Mesylate 6Sunitinib 4ripretinib 2regorafenib 2Specimen Handling 2Paclitaxel 2Magnetic Resonance Spectroscopy 2IDRX-42 2trastuzumab deruxtecan 1pemigatinib 1olverembatinib 1envafolimab 1atezolizumab 1apatinib 1Temozolomide 1Surgical Instruments 1Sorafenib 1Rogaratinib 1Nivolumab 1Midazolam 1Laparoscopy 1Ipilimumab 1Cyclophosphamide 1CTLA-4 Antigen 1Blood Specimen Collection 1Biopsy 14-Aminopyridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Gastrointestinal Stromal Tumors × ripretinib × 90 days × Clear all
NCT05957367 2026-06-02

A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies

Deciphera Pharmaceuticals, LLC

Phase 1/2 Recruiting
94 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT04633122 2026-04-03

A Study to Assess DCC-2618 and Sunitinib in Patients With Advanced GIST After Treatment With Imatinib

Zai Lab (Hong Kong), Ltd.

Phase 2 Completed
108 enrolled 11 charts
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡